Core Viewpoint - China Chemical Engineering Corporation's subsidiary, Ningbo Saiding, is involved in a lawsuit regarding false statements made by Kangde Xin Composite Materials Group, with potential financial implications for the company [1][3][6] Group 1: Lawsuit Details - Ningbo Saiding received a notice from the Suzhou Intermediate People's Court regarding a lawsuit filed by Zhejiang Zhongtai Chuangying Asset Management, claiming losses from investments in Kangde Xin's stock from November 2016 to May 2021 [3][6] - The plaintiff seeks approximately 5.147 billion yuan in damages due to false statements, along with additional claims for commissions and stamp duties totaling around 154,420 yuan and 514,730 yuan respectively [3][6] - Ningbo Saiding is the seventh defendant among eleven total defendants in this case, which was previously filed in Nanjing and has now been transferred to Suzhou without changes to the claims [6] Group 2: Company Position and Financial Impact - China Chemical has preliminarily verified that Ningbo Saiding was not aware of any financial fraud by Kangde Xin while cooperating with them [1][6] - The company assesses that this lawsuit will not have a substantial impact on its current or future profits [6] - As of May 15, the stock price of China Chemical was 8.02 yuan per share, with a total market capitalization of 49 billion yuan, and approximately 105,400 shareholders as of the end of Q1 2025 [6]

Core Viewpoint - China Chemical (601117.SH) announced that its subsidiary, China Chemical Sading Ningbo Engineering Co., Ltd., is involved in a lawsuit concerning securities fraud against Kangde Xin Composite Materials Group Co., Ltd. [1][3] Group 1: Lawsuit Details - Zhejiang Zhongtai Chuangying Asset Management Co., Ltd. claims investment losses of 5.147 billion yuan due to Kangde Xin's false statements from 2016 to 2021 and seeks compensation, including related commissions and taxes [3] - Sading Ningbo is listed as the seventh defendant in the lawsuit, primarily due to previous business dealings with Kangde Xin, but the company asserts it did not knowingly assist in any fraudulent activities [3][4] - The case involves eleven defendants, and China Chemical preliminarily assesses that it will not materially impact current or future profits [3][4] Group 2: Background on Kangde Xin - Kangde Xin was listed in July 2010 and specializes in the research and consulting of polymer composite materials and functional film materials [4] - The company was forced to delist in 2021 after it was found to have fabricated over 10 billion yuan in profits [4] - Zhejiang Zhongtai Chuangying became the second-largest shareholder of Kangde Xin after signing a strategic cooperation agreement in 2016, which was terminated in 2018 [4]

Group 1 - The core issue involves Langyuan Co., Ltd. being penalized by the China Securities Regulatory Commission for financial misconduct, specifically for inflating revenue, costs, and profits through fictitious contracts in 2019 [1] - The inflated figures included an increase in revenue by 52.51 million yuan, costs by 34.94 million yuan, and total profit by 18.17 million yuan, representing 9.03%, 7.94%, and 43.02% of the respective reported figures [1] - A subsequent correction announcement in September 2020 still reflected inflated figures, with adjusted revenue, costs, and profits remaining overstated by 37.88 million yuan, 27.23 million yuan, and 11.25 million yuan, which accounted for 6.68%, 6.17%, and 26.91% of the respective reported figures [1] Group 2 - On the same day the administrative penalty was announced, a board member of Langyuan submitted a resignation letter, stepping down from his positions as director, vice chairman, and member of the remuneration and assessment committee [2] - A lawsuit has been initiated regarding the false statements made by Langyuan, with ongoing proceedings aimed at compensating affected shareholders [3] - Shareholders who purchased shares between April 25, 2018, and April 25, 2023, or between April 30, 2020, and September 12, 2024, may be eligible to file for compensation [3]

Group 1 - The core viewpoint emphasizes the importance of protecting the legal rights of small and medium investors as a foundation for the sustainable and healthy development of the capital market [1] - The current legal framework for protecting small and medium investors is expected to become more robust and effective [1] Group 2 - Small and medium investors are at a disadvantage in terms of investment experience, information access, and analytical skills, making them vulnerable to violations such as false statements, insider trading, and market manipulation [2] - From March 2021 to March 2025, the Beijing Financial Court accepted 9,101 cases of securities fraud liability disputes, with 9,077 cases (99.7%) related to securities false statement liability [2] Group 3 - The legal system for false statement civil lawsuits is more developed, leading to a higher number of lawsuits related to false statements compared to other violations [3] - Investors can also seek compensation for losses caused by insider trading and market manipulation under the Securities Law [3] Group 4 - The Supreme People's Court's new regulations have removed the pre-litigation procedures for false statement civil lawsuits, allowing investors to file lawsuits without waiting for administrative or criminal penalties [4] - The main challenge in these cases lies in the burden of proof, particularly in establishing causation and loss [4] Group 5 - The introduction of the new regulations is expected to ease the burden of proof for investors, but it will take time for the system to fully implement these changes [5] - Future improvements in the litigation process and better communication between lawyers, courts, and regulatory bodies are anticipated [5] Group 6 - The new Securities Law has established mechanisms for representative lawsuits and special representative lawsuits to address collective disputes among investors [6] - The Beijing Financial Court is exploring an innovative "dual-track dual-platform" mechanism for resolving collective disputes, combining representative lawsuits with demonstration judgment mechanisms [6] Group 7 - Both representative lawsuits and demonstration judgments can enhance trial efficiency and reduce the cost of rights protection for investors [7] - The Supreme Court and the Securities Regulatory Commission have established a diversified dispute resolution mechanism to provide alternatives to litigation for investors [7] Group 8 - In false statement liability disputes, accurately identifying the responsible parties is crucial for protecting investors' rights and increasing the cost of violations [8] - The determination of civil liability among various defendants, including issuers and intermediaries, is a key focus in these cases [8] Group 9 - Recent judicial practices have introduced proportional joint liability to determine the responsibility of intermediary institutions in false statement cases [9] - This approach considers the subjective fault of the intermediary and the causal relationship between their negligence and the resulting damages [9] Group 10 - There is often a discrepancy between the amount compensated and the actual losses incurred by investors, which can be confusing [10] - The court determines compensation based on the actual losses incurred due to false statements, which may not cover all losses experienced by the investor [10] Group 11 - The legal basis for claims related to securities false statements is tort liability, which requires precise determination of damages and causation [11] Group 12 - The increase in civil compensation cases related to market manipulation and insider trading highlights the need for judicial interpretations in these areas [12] - The current Securities Law includes provisions for civil liability related to insider trading and market manipulation, but remains somewhat general [12] Group 13 - There is ongoing academic debate regarding the necessity of judicial interpretations for civil compensation related to insider trading and market manipulation [13] - Establishing a clear framework for civil liability in these cases is essential for ensuring investor compensation [13]

Core Viewpoint - Multiple securities firms have disclosed significant litigation matters in their 2024 annual reports, highlighting risks in areas such as securities misrepresentation, stock pledge repurchase, and margin financing disputes, which reflect the risk points in the development of brokerage businesses [1] Group 1: Securities Misrepresentation - Securities misrepresentation has emerged as a major risk point leading to lawsuits against brokerage firms, where investors seek compensation from brokers for losses incurred due to the fraudulent actions of listed companies [1] - In December 2024, individual investors filed lawsuits against Meishang Ecological Landscape Co., Ltd. and Jintongling Technology Group Co., Ltd., along with five brokerage firms, demanding joint compensation for securities misrepresentation [1] - Jintongling has reported inflated or deflated profit figures from 2017 to 2022, with discrepancies reaching as high as 5774.38% in one year, leading to false disclosures in annual reports [3] Group 2: Brokerage Responses - Brokerages such as Everbright Securities and GF Securities have indicated uncertainty regarding the final amount involved in the lawsuits due to the special representative litigation procedure, making it difficult to assess the impact on current or future profits [2] Group 3: Stock Pledge Repurchase Disputes - In addition to securities misrepresentation, several brokerages are embroiled in disputes related to stock pledge repurchase transactions, with Oriental Securities reporting a default involving a principal repayment of 653 million yuan [7] - Guohai Securities has also disclosed multiple stock pledge repurchase disputes, with asset impairment provisions impacting their net profits significantly, including a reduction of 55.08 million yuan in one instance [7][8] Group 4: Legal Responsibilities of Intermediaries - The legal framework imposes joint liability on brokers when securities misrepresentation occurs, allowing investors to sue both the issuer and the broker, which has led to an increase in such cases since the 2022 judicial interpretation [5] - Legal experts emphasize that investors rely on brokers for due diligence, and if brokers fail to fulfill their duties, they may be liable for investor losses [6]

金力泰 系深圳证券交易所A股上市公司。2021年6月15日， 金力泰 发布公告，称公司 董事兼总裁 袁某、控股子公司总经理罗某 计划在6个月内增持 金力泰 股份，增持金额合计不低于3亿元。后 金力泰 两次发布公告，称袁某、罗某上述增持承诺履行期限分别延期至2022年6月15日、9月30 日。 2022年9月30日盘后， 金力泰 公告称袁某、罗某未能在延期期间完成增持计划 。同年10月 20日，中国证券监督管理委员会上海监管局对袁某、罗某采取出具警示函的行政监管措施。同年 12月21日，深圳证券交易所作出《关于对袁某、罗某给予公开谴责处分的决定》。 据上海法治报，该上市公司为上海金力泰化工（以下简称"金力泰"）。 该案是2019年修订《中华人民共和国证券法》以来， 全国首例因上市公司董监高（上市公司董 事、监事和高级管理人员的简称）未履行公开增持承诺引发的证券侵权纠纷案件 。 本案采用示范 判决机制进行审理。 来源|每日经济新闻 据" 上海金融法院 "微信公号，4月25日，上海金融法院公开宣判原告刘某某、郑某某诉被告上海 金某泰化工股份有限公司、袁某、罗某证券虚假陈述责任纠纷一案。 其次，就本案诉争的公开增持承 ...

Core Viewpoint - The Shanghai Financial Court ruled that two executives of Jinmoutai Chemical Co., Ltd. must compensate investors for losses due to their failure to fulfill public shareholding commitments, marking a significant legal precedent under the revised Securities Law of China [3][10]. Group 1: Case Background - The case is the first securities infringement dispute since the 2019 revision of the Securities Law, arising from the failure of company executives to fulfill public shareholding commitments [3]. - The court ordered the defendants, Yuan and Luo, to jointly compensate investor Liu for 506,100 yuan and investor Zheng for 277,400 yuan [1][10]. Group 2: Legal Implications - The case utilized a demonstration judgment mechanism, highlighting the application of Article 84 of the new Securities Law, which mandates disclosure of public commitments and imposes civil liability for non-fulfillment [3][10]. - The court emphasized that the nature of public commitments and the circumstances surrounding their non-fulfillment must be considered to determine if they constitute securities fraud [9][10]. Group 3: Details of the Commitment - In June 2021, Jinmoutai announced that its executives planned to increase their shareholding by at least 300 million yuan within six months, but they failed to fulfill this commitment, leading to regulatory actions against them [4][5]. - The plaintiffs argued that their investment decisions were based on the executives' public commitments, which they claimed constituted securities fraud due to the lack of follow-through [7][10]. Group 4: Court's Findings - The court found that the defendants did not have the necessary funds when they made the commitment and failed to actively seek funding during the extension periods, indicating a lack of genuine intent to fulfill the commitment [10]. - The court ruled that Jinmoutai was not liable for the defendants' actions, as it had fulfilled its disclosure obligations and had no knowledge of the executives' fraudulent intentions [10].

上述案件审理主要有三个要点，公开承诺法律责任判定原则、公开增持承诺性质认定以及责任承担认 定。 时隔近一年，全国首例上市公司董监高"爽约"增持引发的证券侵权纠纷案迎来宣判。 案件审理中，被告辩称已经根据规定及时将增持意愿、资金筹措情况及因资金筹措困难导致延期等情况 书面告知金某泰，因客观上履行能力不足，无法再履行增持承诺，不存在主观上"忽悠式增持"的故意或 过失，对此，公司也及时发布了公告。股价下跌主要是由于市场整体及企业自身经营等其他情况导致， 并非两被告不履行增持承诺导致。 上海金融法院经审理认为，上述案件审理主要有三个要点，公开承诺法律责任判定原则、公开增持承诺 性质认定以及责任承担认定。 本案中，袁某、罗某在首次作出增持承诺时并无资金准备，在后续延期过程中亦未积极筹措资金，且在 面对交易所质询时以过桥资金制作"虚假"存款证明，故难以认定其有增持的真实意愿。从增持主体、承 诺增持金额、市场影响力等角度看，袁某、罗某公开增持承诺信息的披露，对证券市场和投资者预期产 生严重误导，其所主张的未能履行增持承诺的抗辩理由明显不合理，故虚假陈述行为成立且具有重大 性。 此外，公开承诺人袁某、罗某为法定信息披露义务人 ...

21世纪经济报道记者 郭聪聪 北京报道 在证券市场中，信息披露的准确性与及时性关乎广大投资者的切身利益。上市公司实控人、控股股东减 持未披露的情况时有发生，在此情形下公司未对实控人的行为进行披露，是否要承担相应责任？ 北京金融法院在3月27日披露的一起案例给出了明确答案：上市公司（发行人）是信息披露的第一责任 人，对上市公司的诚信责任进行了落实。 上市公司是信息披露的第一责任人 这是一起因上市公司未及时披露实控人、控股股东减持行为而引发的证券责任纠纷。 《白皮书》显示，2021年3月18日至2024年12月31日，北京金融法院的证券纠纷案件占全部民商事案件 收案数的44.07%。证券纠纷案件标的总额达438.24亿元，案均诉讼标的额约为473.98万元。 从案由分布情况来看，在证券类纠纷中，因证券欺诈引起的纠纷占比最高，达9101件。而在证券欺诈责 任纠纷下的四个四级案由中，因证券虚假陈述引发的纠纷案件为9077件，占比高达 99.7%。从行为目的 上看，多为"诱多型"虚假陈述。 北京金融法院经审理认为，虽陈某5月的减持行为于8月被撤销，但重大遗漏型虚假陈述关注的是在应当 披露的时点未按照法律规定的方式方法进 ...